Annual SG&A
$14.59 M
-$1.97 M-11.89%
31 December 2023
Summary:
Eterna Therapeutics annual selling, general & administrative expenses is currently $14.59 million, with the most recent change of -$1.97 million (-11.89%) on 31 December 2023. During the last 3 years, it has risen by +$11.29 million (+342.40%). ERNA annual SG&A is now -11.89% below its all-time high of $16.55 million, reached on 31 December 2022.ERNA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.38 M
-$515.00 K-13.22%
30 September 2024
Summary:
Eterna Therapeutics quarterly selling, general & administrative expenses is currently $3.38 million, with the most recent change of -$515.00 thousand (-13.22%) on 30 September 2024. Over the past year, it has dropped by -$668.00 thousand (-16.50%). ERNA quarterly SG&A is now -37.77% below its all-time high of $5.43 million, reached on 01 June 2022.ERNA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$805.54 M
-$44.95 M-5.91%
30 September 2024
Summary:
Eterna Therapeutics TTM selling, general & administrative expenses is currently -$805.54 million, with the most recent change of -$44.95 million (-5.91%) on 30 September 2024. Over the past year, it has dropped by -$819.47 million (-5883.21%). ERNA TTM SG&A is now -4340.46% below its all-time high of $18.47 million, reached on 01 June 2022.ERNA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ERNA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.9% | -16.5% | -5883.2% |
| 3 y3 years | +342.4% | -21.1% | -5570.9% |
| 5 y5 years | - | - | - |
ERNA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.9% | +342.4% | -37.8% | +30.5% | -178.1% | at low |
| 5 y | 5 years | -11.9% | +342.4% | -37.8% | +508.9% | -4340.5% | at low |
| alltime | all time | -11.9% | +342.4% | -37.8% | +508.9% | -4340.5% | at low |
Eterna Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.38 M(-13.2%) | $15.95 M(-4.0%) |
| June 2024 | - | $3.90 M(-9.7%) | $16.61 M(+8.5%) |
| Mar 2024 | - | $4.32 M(-0.9%) | $15.31 M(+5.0%) |
| Dec 2023 | $14.59 M(-11.9%) | $4.36 M(+7.6%) | $14.59 M(+4.7%) |
| Sept 2023 | - | $4.05 M(+56.3%) | $13.93 M(+5.4%) |
| June 2023 | - | $2.59 M(-27.9%) | $13.22 M(-17.7%) |
| Mar 2023 | - | $3.59 M(-2.9%) | $16.06 M(-5.4%) |
| Dec 2022 | $16.55 M | $3.70 M(+10.7%) | $16.99 M(-3.3%) |
| Sept 2022 | - | $3.34 M(-38.5%) | $17.57 M(-4.8%) |
| June 2022 | - | $5.43 M(+20.4%) | $18.47 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.51 M(+5.3%) | $17.61 M(+19.6%) |
| Dec 2021 | $14.72 M(+346.6%) | - | - |
| Dec 2021 | - | $4.29 M(+1.2%) | $14.72 M(+33.9%) |
| Sept 2021 | - | $4.23 M(-7.6%) | $10.99 M(+40.2%) |
| June 2021 | - | $4.58 M(+182.3%) | $7.84 M(+82.6%) |
| Mar 2021 | - | $1.62 M(+192.3%) | $4.30 M(+15.3%) |
| Dec 2020 | $3.30 M | $555.30 K(-48.8%) | $3.73 M(+17.5%) |
| Sept 2020 | - | $1.08 M(+4.8%) | $3.17 M(+51.9%) |
| June 2020 | - | $1.03 M(-1.8%) | $2.09 M(+98.2%) |
| Mar 2020 | - | $1.05 M | $1.05 M |
FAQ
- What is Eterna Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Eterna Therapeutics?
- What is Eterna Therapeutics annual SG&A year-on-year change?
- What is Eterna Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly SG&A year-on-year change?
- What is Eterna Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Eterna Therapeutics?
- What is Eterna Therapeutics TTM SG&A year-on-year change?
What is Eterna Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ERNA is $14.59 M
What is the all time high annual SG&A for Eterna Therapeutics?
Eterna Therapeutics all-time high annual selling, general & administrative expenses is $16.55 M
What is Eterna Therapeutics annual SG&A year-on-year change?
Over the past year, ERNA annual selling, general & administrative expenses has changed by -$1.97 M (-11.89%)
What is Eterna Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ERNA is $3.38 M
What is the all time high quarterly SG&A for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly selling, general & administrative expenses is $5.43 M
What is Eterna Therapeutics quarterly SG&A year-on-year change?
Over the past year, ERNA quarterly selling, general & administrative expenses has changed by -$668.00 K (-16.50%)
What is Eterna Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ERNA is -$805.54 M
What is the all time high TTM SG&A for Eterna Therapeutics?
Eterna Therapeutics all-time high TTM selling, general & administrative expenses is $18.47 M
What is Eterna Therapeutics TTM SG&A year-on-year change?
Over the past year, ERNA TTM selling, general & administrative expenses has changed by -$819.47 M (-5883.21%)